Skip to main content
SpringerLink
Log in

Early Reports on the Prognostic Implications and Immunotherapeutic Potentials of Cd34 Rich Cord Whole Blood Transfusion in Advanced Breast Cancer with Severe Anemia

  • Chapter
  • First Online:
Regenerative Medicine Using Pregnancy-Specific Biological Substances

  • 774 Accesses

Abstract

Anemia is the commonest comorbidity, which prevents an aggressive and effective treatment initiation in case of advanced cancer. It increases with the progression of the disease.1 Severe anemia can cause subsequent tumor cell hypoxia, which can reduce the tumorocidal effect of each modality of treatment including radiation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Crouch Z, DeSantis ER. Use of erythropoietin-stimulating agents in breast cancer patients: a risk review. Am J Health Syst Pharm. 2009;66(13):1180-1185. Review.

    Article  CAS  PubMed  Google Scholar 

  2. Mith RE Jr, Tchekmedyian S. Practitioners’practical model for managing cancer elated anemia. Oncology (Huntingt). 2002;16(9 Suppl 10):55-63.

    Google Scholar 

  3. Pirker R, Wiesenberger K, Pohl G, Minar W. Anemia in lung cancer: clinical impact and management. Clin Lung Cancer. 2003;5(2):90-97.

    Article  PubMed  Google Scholar 

  4. Tchekmedyian NS. Anemia in cancer patients: significance, epidemiology, and current therapy. Oncology (Huntingt). 2002;16(9 Suppl 10):17-24.

    Google Scholar 

  5. Steensma DP. Management of anemia in patients with cancer. Curr Oncol Rep. 2004;6(4):297-304.

    Article  PubMed  Google Scholar 

  6. Kolesar JM. Novel approaches to anemia associated with cancer and chemotherapy. Am J Health Syst Pharm. 2002;59(15 Suppl 4):S8-S11.

    PubMed  Google Scholar 

  7. Harrison LB, Shasha D, Homel P. Prevalence of anemia in cancer patients undergoing radiotherapy: prognostic significance and treatment. Oncology. 2002;63(Suppl 2):11-18.

    Article  CAS  PubMed  Google Scholar 

  8. Ludwig H, Fritz E. Anemia of cancer patients: patient selection and patient stratification for epoetin treatment. Semin Oncol. 1998;25(3 Suppl 7):35-38.

    CAS  PubMed  Google Scholar 

  9. BCSH Blood Transfusion Task Force. Guideline for the gamma irradiation of the blood components for the prevention of the transfusion associated graft vs host disease. Transfus Med. 1996;6:261.

    Article  Google Scholar 

  10. Goodnough T. Transfusion medicine – blood conservation – second of two parts. N Engl J Med. 1999;340(7):525-533.

    Article  CAS  PubMed  Google Scholar 

  11. Tscherning-Casper C, Papadogiannakis N, Anvret M, et al. The trophoblastic epithelial barrier is not infected in full-term placentae of human immunodeficiency virus-seropositive mothers undergoing antiretroviral therapy. J Virol. 1999;73(11):9673-9678.

    CAS  PubMed  Google Scholar 

  12. Bhattacharya N. Placental umbilical cord whole blood transfusion: a safe and genuine blood substitute for patients of the under-resourced world at emergency. J AM Coll Surg. 2005;200(4):557-563.

    Article  PubMed  Google Scholar 

  13. Bhattacharya N, Mukherjee KL, Chettri MK, Banerjee T, Mani U, Bhattacharya S. A study report of 174 units of placental umbilical cord whole blood transfusion in 62 patients as a rich source of fetal hemoglobin supply in different indications of blood transfusion. Clin Exp Obstet Gynecol. 2001;28(1):47-52.

    CAS  PubMed  Google Scholar 

  14. Hussain SA, Palmer DH, Stevens A, Spooner D, Poole CJ, Rea DW. Role of chemotherapy in breast cancer. Expert Rev Anticancer Ther. 2005;5(6):1095-1110.

    Article  CAS  PubMed  Google Scholar 

  15. Lee Tzong-Hae, Paglieroni Teresa, Ohto Hitoshi, Holland Paul V, Busch Michael P. Survival of donor leukocyte ­subpopulations in immunocompetent transfusion recipients: frequent long-term microchimerism in severe trauma patients. Blood. 1999;93(9):3127-3139.

    CAS  PubMed  Google Scholar 

  16. Utter GH, Owings JT, Lee TH, et al. Blood transfusion is associated with donor leukocyte microchimerism in trauma patients. J Trauma. 2004;57(4):702-707. discussion 707–708.

    Article  PubMed  Google Scholar 

  17. Lee TH, Paglieroni T, Utter GH, et al. High-level long-term white blood cell microchimerism after transfusion of ­leukoreduced blood components to patients resuscitated after severe traumatic injury. Transfusion. 2005;45(8):1280-1290.

    Article  PubMed  Google Scholar 

  18. Szekeres-Bartho J. Immunological relationship between the mother and the fetus. Int Rev Immunol. 2002;21(6):471-495.

    Article  CAS  PubMed  Google Scholar 

  19. Carosella ED. HLA-G: fetomaternal tolerance. C R Acad Sci III. 2000;323(8):675-680.

    CAS  PubMed  Google Scholar 

  20. Ishitani A, Sageshima N, Lee N, et al. Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J Immunol. 2003;171:1376-1384.

    CAS  PubMed  Google Scholar 

  21. Sargent IL. Maternal and fetal immune responses during pregnancy. Exp Clin Immunogenet. 1993;10:85.

    CAS  PubMed  Google Scholar 

  22. Le Bouteiller P, Rodriguez AM, Mallet V, Girr M, Guillaudeux T, Lenfant F. Placental expression of HLA class I genes. Am J Reprod Immunol. 1996;35:216.

    PubMed  Google Scholar 

  23. McCracken S, Layton JE, Shorter SC, Starkey PM, Barlow DH, Mardon HJ. Expression of granulocyte-colony stimulating factor and its receptor is regulated during the development of the human placenta. J Endocrinol. 1996;149:249-258.

    Article  CAS  PubMed  Google Scholar 

  24. Lee T-H, Donegan EA, Slichter S, Busch MP. Transient increase in circulating donor leukocytes following allogeneic transfusions in immunocompetent recipients compatible with donor cell proliferation. Blood. 1995;85:1207.

    CAS  PubMed  Google Scholar 

  25. Madrigal JA, Cohen SBA, Gluckman E, Charron DJ. Does cord blood transplantation result in lower graft vs host disease.It takes more than two to tango. Hum Immunol. 1997;56:1-5.

    Article  CAS  PubMed  Google Scholar 

  26. Chang M-DY, Polar JW, Khalili H, et al. Mouse placental macrophages have a decreased ability to present an antigen. Proc Natl Acad Sci USA. 1993;90:452-456.

    Article  Google Scholar 

  27. Roitt I, Brostoff J, Male D. Immunology. 6th ed. London, UK: Mosby; 2001:205-206: Chap. 12.

    Google Scholar 

  28. Joshi SS, Vu UE, Lovgren TR, et al. Comparison of phenotypic and functional dendritic cells derived from human umbilical cord blood and peripheral blood mononuclear cells. J Hematother Stem Cell Res. 2002;11(2):337-347.

    Article  PubMed  Google Scholar 

  29. Schmitz-Winnenthal FH, Volk C, Z’graggen K, et al. High frequencies of functional tumor-reactive T cells in bone marrow and blood of pancreatic cancer patients. Cancer Res. 2005;65(21):10079-10087.

    Article  CAS  PubMed  Google Scholar 

  30. Joshi AD, Clark EM, Wang P, et al. Immunotherapy of human neuroblastoma using umbilical cord blood-derived effector cells. J Neuroimmune Pharmacol. 2007;2(2):202-212. Epub 2006 Oct 10.

    Article  PubMed  Google Scholar 

  31. Migliaccio AR, Alfani E, Di Giacomo V, Cieri M, Migliaccio G. Ex vivo amplification of T cells from human cord blood. Pathol Biol (Paris). 2005;53(3):151-158. Review.

    CAS  Google Scholar 

Download references

Acknowledgment

The Department of Science and Technology, Government of West Bengal, supported the investigator with a research grant during his tenure at Bijoygarh State Hospital from 1999 to 2006. The author gratefully acknowledges the support of the patients who volunteered for this study. The guidance of Prof. K. L. Mukherjee of Biochemistry, and Prof. M. K. Chhetri, the former Director of Health Services, West Bengal, is also acknowledged.

Author information

Authors and Affiliations

  1. Department of General Surgery, Obstertrics and Gynaecology and Clinical Immunology, Advanced Medical Research Institute, B.P. Poddar Hospital and Vidyasagore Hospital, Gol Park, Kolkata, 700034, India

    Niranjan Bhattacharya

Authors
  1. Niranjan Bhattacharya
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Advanced Medical Research Inst., B.P.Poddar Hospital, Vidyasagar Hospital, Kolkata, India

    Niranjan Bhattacharya

  2. Dept. Obstetrics & Gynaecology, Boston University Medical Centre, E. Concord Street 85, Boston, 02118, Massachusetts, USA

    Phillip Stubblefield

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer London

About this chapter

Cite this chapter

Bhattacharya, N. (2011). Early Reports on the Prognostic Implications and Immunotherapeutic Potentials of Cd34 Rich Cord Whole Blood Transfusion in Advanced Breast Cancer with Severe Anemia. In: Bhattacharya, N., Stubblefield, P. (eds) Regenerative Medicine Using Pregnancy-Specific Biological Substances. Springer, London. https://doi.org/10.1007/978-1-84882-718-9_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-84882-718-9_13

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84882-717-2

  • Online ISBN: 978-1-84882-718-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation